Nanoportal Biotech

mRNA-based therapeutics have demonstrated immense potential to revolutionize disease treatment. However, the broad application of genetic medicines remains limited by the challenges of current delivery technologies. At Nanoportal Biotech, our mission is to leverage natural biological mechanisms to develop the next generation of gene delivery systems. We have successfully invented the world's first coacervate-based nucleic acid delivery platform based on mammalian endogenous protein, offering a novel solution for efficient gene delivery.